TrialJournal of the American Heart Association2019

Epoetin Beta and C-Terminal Fibroblast Growth Factor 23 in Patients With Chronic Heart Failure and Chronic Kidney Disease.

Michele F Eisenga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.